Distinct Molecular Subtypes of RSV Bronchiolitis Identified
MONDAY, June 21, 2021 (HealthDay News) — Distinct molecular subtypes of respiratory...
Pulmonology
Convalescent Plasma May Cut Deaths in Hematologic Cancer and COVID-19
MONDAY, June 21, 2021 (HealthDay News) — For hospitalized patients with hematologic cancers...
AHA Advises OSA Screening for Those With CV Risk, Conditions
MONDAY, June 21, 2021 (HealthDay News) — People with cardiovascular risk factors or...
Riociguat May Benefit PAH Patients with Poor PDE5i Therapy Response
Patients switched to the sGC stimulator had fewer hospitalizations Switching pulmonary arterial...
Long-Term Disparities in Respiratory Health Persist in the U.S.
FRIDAY, June 18, 2021 (HealthDay News) — Income- and education-based disparities in...
Obesity Tied to Long-Term COVID-19 Complications
FRIDAY, June 18, 2021 (HealthDay News) — Moderate and severe obesity is associated with a...
U.S. Supreme Court Strikes Down Challenge to Affordable Care Act
THURSDAY, June 17, 2021 (HealthDay News) — The landmark Affordable Care Act, which has...
Disparities in COVID-19 Vaccination ID’d Among Health Employees
WEDNESDAY, June 16, 2021 (HealthDay News) — Among health care system employees, there are...
Primary care providers’ role in newborn screening result notification for cystic fibrosis.
To explore primary care providers’ (PCPs’) role in result notification for newborn screening (NBS) for cystic fibrosis (CF), given that expanded NBS has increased the number of positive screening test results,...
Newborn screening for cystic fibrosis: Role of primary care providers in caring for infants with positive screening results.
To explore primary care providers’ (PCPs’) preferred roles and confidence in caring for infants receiving a positive cystic fibrosis (CF) newborn screening (NBS) result, as well as management of CF family planning...
Determinants of Lung Fissure Completeness.
New advanced bronchoscopic treatment options for patients with severe COPD have led to increased interest for COPD phenotyping, including fissure completeness.We investigated clinical, environmental, and genetic factors...
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial.
SARS-CoV-2 entry in human cells depends on angiotensin-converting enzyme 2, which can be upregulated by inhibitors of the renin-angiotensin system (RAS). We aimed to test our hypothesis that discontinuation of chronic treatment...
- 1
- ...
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- 163
- 164
- 165
- 166
- 167
- 168
- 169
- 170
- 171
- 172
- 173
- 174
- 175
- 176
- 177
- 178
- 179
- 180
- 181
- 182
- 183
- 184
- 185
- 186
- 187
- 188
- 189
- 190
- 191
- 192
- 193
- 194
- 195
- 196
- 197
- 198
- 199
- 200
- 201
- 202
- 203
- 204
- 205
- 206
- 207
- 208
- 209
- 210
- 211
- 212
- 213
- 214
- 215
- 216
- 217
- 218
- 219
- 220
- 221
- 222
- 223
- 224
- 225
- 226
- 227
- 228
- 229
- 230
- 231
- 232
- 233
- 234
- 235
- 236
- 237
- 238
- 239
- 240
- 241
- 242
- 243
- 244
- ...
- 245